1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV
Effectiveness of early a-interferon therapy for hepatitis C virus infection recurrence after liver transplantation
โ Scribed by O. Boillot; F. Berger; E. Rasolofo; F. Mion; P. Chevallier; D. Gille; P. Paliard
- Book ID
- 115134727
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 171 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The aims of this pilot study were to evaluate the safety and efficacy of interferon-alpha 2b for treatment of hepatitis C virus infection in liver transplant recipients, to monitor changes in hepatitis C virus RNA levels with treatment and to determine pretreatment parameters predictive of a complet
## Identification of the hepatitis C virus-the main cause of posttransfusion and sporadic non -A, non-B hepatitisand the development of a diagnostic serological test have allowed us to study possible recurrence of this type of hepatitis after liver transplantation. Six of 34 consecutive transplant